Legal Representation
Attorney
Howard Russell
USPTO Deadlines
Next Deadline
1228 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20190514)
Due Date
May 14, 2029
Grace Period Ends
November 14, 2029
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 28, 2025 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Aug 28, 2025 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Aug 28, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Apr 22, 2025 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| May 14, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| May 14, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 26, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 26, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 6, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 20, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 4, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 4, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 4, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 4, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 4, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 26, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 25, 2018 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 24, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 19, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Surgical treatment of sinus pain and conditions, namely, with septoplasty, cryosurgery, nasal endoscopy, endoscopic sinus surgery, surgical treatment of turbinates, balloon sinuplasty, treatment of epistaxis, treatment of nasal polyps, treatment of stenosis, surgical treatment of allergic rhinitis, treatment of chronic runny nose; medical treatment of the nose and sinuses, treatment of nasal polyps, treatment of epistaxis, treatment of inflammatory disorders of the nasal airway, treatment of infection of the nasal airway, treatment of allergic rhinitis, treatment of oncologic disorders of the nasal airway, treatment of changes in the sense of smell, treatment of nasal airway obstructions; treatment for snoring and sleep apnea relief, namely, treatment of nasal airway obstructions, treatment of oral pharyngeal pathology, surgical treatment of the paranasal airway, treatment using oral appliances, treatment using Continuous Positive Airway Pressure (CPAP) machines, and treatment using Bilevel Positive Airway Pressure (BiPAP) machines; medical testing for diagnostic and treatment services for allergies and immunotherapy services, namely, with cryosurgery, avoidance therapy, pharmacotherapy, and immunotherapy; medical treating hearing loss with the use of hearing aids and other hearing assistant devices, performing audiograms; surgical treatment of the ears, namely, treating hearing loss, treating hearing infections, treating oncologic disorders of the ears, treating inflammation of the ears; treatment of general ENT (Ear, Nose and Throat) pathology, namely, treatment of pediatric otolaryngology pathology, tonsillectomy, adenoidectomy, myringotomy and tube placement; medical treatment of endocrinologic disorders of the head and neck, treatment of major and minor salivary gland disease, treatment of oncologic conditions involving the head and neck, treatment of skin related pathology, treatment of congenital and acquired disorders, treatment of neck masses, treatment of laryngeal pathology, treatment of chronic ear infections, namely, with myringotomy and tube placement; all of the foregoing being medical services
First Use Anywhere:
Sep 14, 2018
First Use in Commerce:
Sep 14, 2018
Additional Information
Design Mark
The mark consists of the letters "MN" and a design. The letters "MN" appear inside a double rectangular border with the "M" shaded, surrounded by unshaded triangular spaces and the "N" unshaded surrounded by triangular shaded spaces. The triangular space under the "N" forms the design of a nose.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
MODERN NOSE
Classification
International Classes
044